Revision history
MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer — 1 version recorded. Nothing here has been overwritten.
-
MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer
From the publisher, in order, with its history intact.
MHRA approves Retifanlimab (ZYNYZ) for the treatment of advanced anal cancer — 1 version recorded. Nothing here has been overwritten.